Skip to content

Evaluating T Cell Changes and Activation in Cancer Patient Using Two PET Tracers (iRelate)

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509486-20-00
Acronym
2023-509486-20-00
Enrollment
34
Registered
2024-05-22
Start date
2024-05-29
Completion date
Unknown
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer, Esophageal Cancer, Melanoma, Non-Small Cell Lung Carcinoma

Brief summary

Main trial endpoints and their analysis:  The spatial overlap of the regions of uptake for both PET tracers will be assessed using the Dice Similarity Coefficient (DSC) as an established method.  The Pearson correlation coefficient between each tracer tumor uptake and the T cell features in regions of concordance and discordance.

Detailed description

Secondary trial endpoints and their analysis:  The Pearson correlation coefficient between each tracer tumor uptake and percentage of residual viable tumor cells (VTC) in regions of concordance and discordance and the maximal VTC of the whole of the tumor.  The Pearson correlation coefficient between each tracer uptake and the T cell features in resected lymph nodes (if present).

Interventions

DRUGZr89
DRUGNELARABINE

Sponsors

Amsterdam UMC
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Main trial endpoints and their analysis:  The spatial overlap of the regions of uptake for both PET tracers will be assessed using the Dice Similarity Coefficient (DSC) as an established method.  The Pearson correlation coefficient between each tracer tumor uptake and the T cell features in regions of concordance and discordance.

Secondary

MeasureTime frame
Secondary trial endpoints and their analysis:  The Pearson correlation coefficient between each tracer tumor uptake and percentage of residual viable tumor cells (VTC) in regions of concordance and discordance and the maximal VTC of the whole of the tumor.  The Pearson correlation coefficient between each tracer uptake and the T cell features in resected lymph nodes (if present).

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026